CAH Extends CVS Health Distribution Agreements Through June 2032, Reaffirms FY27 EPS Guidance
· The NYC Memo
Cardinal Health, Inc. announced October 1, 2026, a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 2032. The company simultaneously reaffirmed its fiscal year 2027 non-GAAP EPS guidance range of $12.40 to $12.60 and its long-term non-GAAP EPS growth guidance of 12% to 14%.